These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 19758647)

  • 1. Editorial comment.
    Rosser CJ
    J Urol; 2009 Nov; 182(5):2272; discussion 2273. PubMed ID: 19758647
    [No Abstract]   [Full Text] [Related]  

  • 2. Lack of an effect of high dose isoflavones in men with prostate cancer undergoing androgen deprivation therapy.
    Sharma P; Wisniewski A; Braga-Basaria M; Xu X; Yep M; Denmeade S; Dobs AS; DeWeese T; Carducci M; Basaria S
    J Urol; 2009 Nov; 182(5):2265-72. PubMed ID: 19758646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing the side effects of androgen-deprivation therapy.
    J Support Oncol; 2007 Feb; 5(2):87-8. PubMed ID: 17348368
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial comment on: new treatment approaches for prostate cancer based on peptide analogues.
    Bamias A; Dimopoulos MA
    Eur Urol; 2008 May; 53(5):899-900. PubMed ID: 18201817
    [No Abstract]   [Full Text] [Related]  

  • 5. Is NNT AOK?
    Lee WR
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):640-1. PubMed ID: 15708240
    [No Abstract]   [Full Text] [Related]  

  • 6. What effect does androgen suppression therapy have on frequency and timing of fatal myocardial infarctions?
    Holzbeierlein JM
    Nat Clin Pract Oncol; 2008 Feb; 5(2):74-5. PubMed ID: 17971802
    [No Abstract]   [Full Text] [Related]  

  • 7. Major depressive disorder.
    Saini A; Ardine M; Berruti A
    N Engl J Med; 2008 Apr; 358(17):1868-9. PubMed ID: 18434660
    [No Abstract]   [Full Text] [Related]  

  • 8. Metformin for the prevention of androgen deprivation induced metabolic syndrome, obesity and type 2 diabetes.
    Cohen P
    Med Hypotheses; 2009 Feb; 72(2):227-8. PubMed ID: 19038502
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular disease with androgen deprivation: the (forgotten) role of testosterone.
    Aragon-Ching JB
    J Clin Oncol; 2009 Dec; 27(35):e261; author reply e262. PubMed ID: 19884519
    [No Abstract]   [Full Text] [Related]  

  • 10. Hot flashes in men: an update.
    Harv Mens Health Watch; 2005 Aug; 10(1):7. PubMed ID: 16201033
    [No Abstract]   [Full Text] [Related]  

  • 11. Can exercise ameliorate the increased risk of cardiovascular disease and diabetes associated with ADT?
    Galvão DA; Newton RU; Taaffe DR; Spry N
    Nat Clin Pract Urol; 2008 Jun; 5(6):306-7. PubMed ID: 18431358
    [No Abstract]   [Full Text] [Related]  

  • 12. "Staging the aging" when considering androgen deprivation therapy for older men with prostate cancer.
    Dale W
    J Clin Oncol; 2009 Jul; 27(21):3420-2. PubMed ID: 19506150
    [No Abstract]   [Full Text] [Related]  

  • 13. Breast disorders in men.
    Harv Mens Health Watch; 2007 Nov; 12(4):4-6. PubMed ID: 18217255
    [No Abstract]   [Full Text] [Related]  

  • 14. [Management of the side effects of androgenic deprivation].
    Lebret T; Méjean A
    Prog Urol; 2008 Nov; 18 Suppl 7():S338-42. PubMed ID: 19070813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular and metabolic complications during androgen deprivation: exercise as a potential countermeasure.
    Galvão DA; Taaffe DR; Spry N; Joseph D; Newton RU
    Prostate Cancer Prostatic Dis; 2009; 12(3):233-40. PubMed ID: 19488067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degarelix (firmagon) for prostate cancer.
    Med Lett Drugs Ther; 2009 Oct; 51(1323):82-3. PubMed ID: 19838145
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial comment to involvement of estrogen receptors in prostatic diseases.
    Takahashi S
    Int J Urol; 2012 Jun; 19(6):522-3. PubMed ID: 22621219
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial comment.
    Nguyen PL
    Urology; 2016 Jan; 87():152. PubMed ID: 27243087
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Editorial comment.
    Goldenberg SL; Gleave ME; Bruchovsky N; Rennie P
    J Urol; 1997 Jun; 157(6):2267. PubMed ID: 9146650
    [No Abstract]   [Full Text] [Related]  

  • 20. Androgen deprivation therapy and prostate cancer duration.
    Williams SG; Pickles T; Buyyounouski MK
    J Clin Oncol; 2009 Dec; 27(34):e228; author reply e229. PubMed ID: 19884533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.